APA (7th ed.) Citation

F, L., DT, M., KD, K., D, T., JH, S., SC, R., . . . FO, B. (2025). Coagulopathy, injury severity and bleeding progression but not prior antiplatelet and anticoagulation therapies drive prognosis in patients with moderate to severe traumatic brain injury. Frontiers in neurology, 16, 1592583. https://doi.org/10.3389/fneur.2025.1592583

Chicago Style (17th ed.) Citation

F, Lieschke, et al. "Coagulopathy, Injury Severity and Bleeding Progression but Not Prior Antiplatelet and Anticoagulation Therapies Drive Prognosis in Patients with Moderate to Severe Traumatic Brain Injury." Frontiers in Neurology 16 (2025): 1592583. https://doi.org/10.3389/fneur.2025.1592583.

MLA (9th ed.) Citation

F, Lieschke, et al. "Coagulopathy, Injury Severity and Bleeding Progression but Not Prior Antiplatelet and Anticoagulation Therapies Drive Prognosis in Patients with Moderate to Severe Traumatic Brain Injury." Frontiers in Neurology, vol. 16, 2025, p. 1592583, https://doi.org/10.3389/fneur.2025.1592583.